Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2001 Nov;109(11):1175–1183. doi: 10.1289/ehp.011091175

Hypospadias and endocrine disruption: is there a connection?

L S Baskin 1, K Himes 1, T Colborn 1
PMCID: PMC1240480  PMID: 11713004

Abstract

Hypospadias is one of the most common congenital anomalies in the United States, occurring in approximately 1 in 250 newborns or roughly 1 in 125 live male births. It is the result of arrested development of the urethra, foreskin, and ventral surface of the penis where the urethral opening may be anywhere along the shaft, within the scrotum, or in the perineum. The only treatment is surgery. Thus, prevention is imperative. To accomplish this, it is necessary to determine the etiology of hypospadias, the majority of which have been classified as idiopathic. In this paper we briefly describe the normal development of the male external genitalia and review the prevalence, etiology, risk factors, and epidemiology of hypospadias. The majority of hypospadias are believed to have a multifactorial etiology, although a small percentage do result from single gene mutations. Recent findings suggest that some hypospadias could be the result of disrupted gene expression. Discoveries about the antiandrogenic mechanisms of action of some contemporary-use chemicals have provided new knowledge about the organization and development of the urogenital system and may provide additional insight into the etiology of hypospadias and direction for prevention.

Full Text

The Full Text of this article is available as a PDF (770.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaronson I. A., Cakmak M. A., Key L. L. Defects of the testosterone biosynthetic pathway in boys with hypospadias. J Urol. 1997 May;157(5):1884–1888. [PubMed] [Google Scholar]
  2. Aarskog D. Maternal progestins as a possible cause of hypospadias. N Engl J Med. 1979 Jan 11;300(2):75–78. doi: 10.1056/NEJM197901113000206. [DOI] [PubMed] [Google Scholar]
  3. Aho M., Koivisto A. M., Tammela T. L., Auvinen A. Is the incidence of hypospadias increasing? Analysis of Finnish hospital discharge data 1970-1994. Environ Health Perspect. 2000 May;108(5):463–465. doi: 10.1289/ehp.00108463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Albers N., Ulrichs C., Glüer S., Hiort O., Sinnecker G. H., Mildenberger H., Brodehl J. Etiologic classification of severe hypospadias: implications for prognosis and management. J Pediatr. 1997 Sep;131(3):386–392. doi: 10.1016/s0022-3476(97)80063-7. [DOI] [PubMed] [Google Scholar]
  5. Alléra A., Herbst M. A., Griffin J. E., Wilson J. D., Schweikert H. U., McPhaul M. J. Mutations of the androgen receptor coding sequence are infrequent in patients with isolated hypospadias. J Clin Endocrinol Metab. 1995 Sep;80(9):2697–2699. doi: 10.1210/jcem.80.9.7673412. [DOI] [PubMed] [Google Scholar]
  6. Baskin L. S., Duckett J. W. Buccal mucosa grafts in hypospadias surgery. Br J Urol. 1995 Dec;76 (Suppl 3):23–30. doi: 10.1111/j.1464-410x.1995.tb07814.x. [DOI] [PubMed] [Google Scholar]
  7. Benson G. V., Lim H., Paria B. C., Satokata I., Dey S. K., Maas R. L. Mechanisms of reduced fertility in Hoxa-10 mutant mice: uterine homeosis and loss of maternal Hoxa-10 expression. Development. 1996 Sep;122(9):2687–2696. doi: 10.1242/dev.122.9.2687. [DOI] [PubMed] [Google Scholar]
  8. Bentvelsen F. M., Brinkmann A. O., van der Linden J. E., Schröder F. H., Nijman J. M. Decreased immunoreactive androgen receptor levels are not the cause of isolated hypospadias. Br J Urol. 1995 Sep;76(3):384–388. doi: 10.1111/j.1464-410x.1995.tb07719.x. [DOI] [PubMed] [Google Scholar]
  9. Berg R., Svensson J., Aström G. Social and sexual adjustment of men operated for hypospadias during childhood: a controlled study. J Urol. 1981 Mar;125(3):313–317. doi: 10.1016/s0022-5347(17)55019-3. [DOI] [PubMed] [Google Scholar]
  10. Bergström R., Adami H. O., Möhner M., Zatonski W., Storm H., Ekbom A., Tretli S., Teppo L., Akre O., Hakulinen T. Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst. 1996 Jun 5;88(11):727–733. doi: 10.1093/jnci/88.11.727. [DOI] [PubMed] [Google Scholar]
  11. Blount B. C., Silva M. J., Caudill S. P., Needham L. L., Pirkle J. L., Sampson E. J., Lucier G. W., Jackson R. J., Brock J. W. Levels of seven urinary phthalate metabolites in a human reference population. Environ Health Perspect. 2000 Oct;108(10):979–982. doi: 10.1289/ehp.00108979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Brock J. W., Melnyk L. J., Caudill S. P., Needham L. L., Bond A. E. Serum levels of several organochlorine pesticides in farmers correspond with dietary exposure and local use history. Toxicol Ind Health. 1998 Jan-Apr;14(1-2):275–289. doi: 10.1177/074823379801400117. [DOI] [PubMed] [Google Scholar]
  13. Carlsen E., Giwercman A., Keiding N., Skakkebaek N. E. Declining semen quality and increasing incidence of testicular cancer: is there a common cause? Environ Health Perspect. 1995 Oct;103 (Suppl 7):137–139. doi: 10.1289/ehp.95103s7137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Cheng W., Mya G. H., Saing H. Associated anomalies in patients with undescended testes. J Trop Pediatr. 1996 Aug;42(4):204–206. doi: 10.1093/tropej/42.4.204. [DOI] [PubMed] [Google Scholar]
  15. Cohn M. J., Bright P. E. Molecular control of vertebrate limb development, evolution and congenital malformations. Cell Tissue Res. 1999 Apr;296(1):3–17. doi: 10.1007/s004410051261. [DOI] [PubMed] [Google Scholar]
  16. Coscrove M. D., Benton B., Henderson B. E. Male genitourinary abnormalities and maternal diethylstilbestrol. J Urol. 1977 Feb;117(2):220–222. doi: 10.1016/s0022-5347(17)58407-4. [DOI] [PubMed] [Google Scholar]
  17. Curley A., Copeland M. F., Kimbrough R. D. Chlorinated hydrocarbon insecticides in organs of stillborn and blood of newborn babies. Arch Environ Health. 1969 Nov;19(5):628–632. doi: 10.1080/00039896.1969.10666901. [DOI] [PubMed] [Google Scholar]
  18. Dolk H., Vrijheid M., Armstrong B., Abramsky L., Bianchi F., Garne E., Nelen V., Robert E., Scott J. E., Stone D. Risk of congenital anomalies near hazardous-waste landfill sites in Europe: the EUROHAZCON study. Lancet. 1998 Aug 8;352(9126):423–427. doi: 10.1016/s0140-6736(98)01352-x. [DOI] [PubMed] [Google Scholar]
  19. Dollé P., Izpisúa-Belmonte J. C., Brown J. M., Tickle C., Duboule D. HOX-4 genes and the morphogenesis of mammalian genitalia. Genes Dev. 1991 Oct;5(10):1767–1767. doi: 10.1101/gad.5.10.1767. [DOI] [PubMed] [Google Scholar]
  20. Donnenfeld A. E., Schrager D. S., Corson S. L. Update on a family with hand-foot-genital syndrome: hypospadias and urinary tract abnormalities in two boys from the fourth generation. Am J Med Genet. 1992 Nov 1;44(4):482–484. doi: 10.1002/ajmg.1320440419. [DOI] [PubMed] [Google Scholar]
  21. Fisch H., Golden R. J., Libersen G. L., Hyun G. S., Madsen P., New M. I., Hensle T. W. Maternal age as a risk factor for hypospadias. J Urol. 2001 Mar;165(3):934–936. [PubMed] [Google Scholar]
  22. Foster W., Chan S., Platt L., Hughes C. Detection of endocrine disrupting chemicals in samples of second trimester human amniotic fluid. J Clin Endocrinol Metab. 2000 Aug;85(8):2954–2957. doi: 10.1210/jcem.85.8.6850. [DOI] [PubMed] [Google Scholar]
  23. Fredell L., Lichtenstein P., Pedersen N. L., Svensson J., Nordenskjöld A. Hypospadias is related to birth weight in discordant monozygotic twins. J Urol. 1998 Dec;160(6 Pt 1):2197–2199. doi: 10.1097/00005392-199812010-00084. [DOI] [PubMed] [Google Scholar]
  24. Fritz G., Czeizel A. E. Abnormal sperm morphology and function in the fathers of hypospadiacs. J Reprod Fertil. 1996 Jan;106(1):63–66. doi: 10.1530/jrf.0.1060063. [DOI] [PubMed] [Google Scholar]
  25. Fryns J. P., Vogels A., Decock P., van den Berghe H. The hand-foot-genital syndrome: on the variable expression in affected males. Clin Genet. 1993 May;43(5):232–234. doi: 10.1111/j.1399-0004.1993.tb03808.x. [DOI] [PubMed] [Google Scholar]
  26. Garry V. F., Schreinemachers D., Harkins M. E., Griffith J. Pesticide appliers, biocides, and birth defects in rural Minnesota. Environ Health Perspect. 1996 Apr;104(4):394–399. doi: 10.1289/ehp.96104394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Gearhart J. P., Linhard H. R., Berkovitz G. D., Jeffs R. D., Brown T. R. Androgen receptor levels and 5 alpha-reductase activities in preputial skin and chordee tissue of boys with isolated hypospadias. J Urol. 1988 Nov;140(5 Pt 2):1243–1246. doi: 10.1016/s0022-5347(17)42014-3. [DOI] [PubMed] [Google Scholar]
  28. Gill W. B., Schumacher G. F., Bibbo M., Straus F. H., 2nd, Schoenberg H. W. Association of diethylstilbestrol exposure in utero with cryptorchidism, testicular hypoplasia and semen abnormalities. J Urol. 1979 Jul;122(1):36–39. doi: 10.1016/s0022-5347(17)56240-0. [DOI] [PubMed] [Google Scholar]
  29. Gray L. E., Jr, Ostby J., Cooper R. L., Kelce W. R. The estrogenic and antiandrogenic pesticide methoxychlor alters the reproductive tract and behavior without affecting pituitary size or LH and prolactin secretion in male rats. Toxicol Ind Health. 1999 Jan-Mar;15(1-2):37–47. doi: 10.1177/074823379901500105. [DOI] [PubMed] [Google Scholar]
  30. Gray L. E., Jr, Ostby J., Monosson E., Kelce W. R. Environmental antiandrogens: low doses of the fungicide vinclozolin alter sexual differentiation of the male rat. Toxicol Ind Health. 1999 Jan-Mar;15(1-2):48–64. doi: 10.1177/074823379901500106. [DOI] [PubMed] [Google Scholar]
  31. Gray L. E., Jr Xenoendocrine disrupters: laboratory studies on male reproductive effects. Toxicol Lett. 1998 Dec 28;102-103:331–335. doi: 10.1016/s0378-4274(98)00327-0. [DOI] [PubMed] [Google Scholar]
  32. Guillette L. J., Jr, Brock J. W., Rooney A. A., Woodward A. R. Serum concentrations of various environmental contaminants and their relationship to sex steroid concentrations and phallus size in juvenile American alligators. Arch Environ Contam Toxicol. 1999 May;36(4):447–455. doi: 10.1007/pl00006617. [DOI] [PubMed] [Google Scholar]
  33. Gupta C., Chandorkar A., Nguyen A. P. Activation of androgen receptor in epidermal growth factor modulation of fetal mouse sexual differentiation. Mol Cell Endocrinol. 1996 Oct 14;123(1):89–95. doi: 10.1016/0303-7207(96)03899-3. [DOI] [PubMed] [Google Scholar]
  34. Gupta C., Siegel S., Ellis D. The role of EGF in testosterone-induced reproductive tract differentiation. Dev Biol. 1991 Jul;146(1):106–116. doi: 10.1016/0012-1606(91)90451-8. [DOI] [PubMed] [Google Scholar]
  35. Haake J., Kelley M., Keys B., Safe S. The effects of organochlorine pesticides as inducers of testosterone and benzo[a]pyrene hydroxylases. Gen Pharmacol. 1987;18(2):165–169. doi: 10.1016/0306-3623(87)90244-8. [DOI] [PubMed] [Google Scholar]
  36. Haraguchi R., Suzuki K., Murakami R., Sakai M., Kamikawa M., Kengaku M., Sekine K., Kawano H., Kato S., Ueno N. Molecular analysis of external genitalia formation: the role of fibroblast growth factor (Fgf) genes during genital tubercle formation. Development. 2000 Jun;127(11):2471–2479. doi: 10.1242/dev.127.11.2471. [DOI] [PubMed] [Google Scholar]
  37. Harris E. L. Genetic epidemiology of hypospadias. Epidemiol Rev. 1990;12:29–40. doi: 10.1093/oxfordjournals.epirev.a036060. [DOI] [PubMed] [Google Scholar]
  38. Hayes H. M., Jr, Wilson G. P. Hospital incidence of hypospadias in dogs in North America. Vet Rec. 1986 May 31;118(22):605–607. doi: 10.1136/vr.118.22.605. [DOI] [PubMed] [Google Scholar]
  39. Henderson B. E., Benton B., Cosgrove M., Baptista J., Aldrich J., Townsend D., Hart W., Mack T. M. Urogenital tract abnormalities in sons of women treated with diethylstilbestrol. Pediatrics. 1976 Oct;58(4):505–507. [PubMed] [Google Scholar]
  40. Hiort O., Klauber G., Cendron M., Sinnecker G. H., Keim L., Schwinger E., Wolfe H. J., Yandell D. W. Molecular characterization of the androgen receptor gene in boys with hypospadias. Eur J Pediatr. 1994 May;153(5):317–321. doi: 10.1007/BF01956409. [DOI] [PubMed] [Google Scholar]
  41. Hsieh-Li H. M., Witte D. P., Weinstein M., Branford W., Li H., Small K., Potter S. S. Hoxa 11 structure, extensive antisense transcription, and function in male and female fertility. Development. 1995 May;121(5):1373–1385. doi: 10.1242/dev.121.5.1373. [DOI] [PubMed] [Google Scholar]
  42. Hurst C. H., DeVito M. J., Setzer R. W., Birnbaum L. S. Acute administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in pregnant Long Evans rats: association of measured tissue concentrations with developmental effects. Toxicol Sci. 2000 Feb;53(2):411–420. doi: 10.1093/toxsci/53.2.411. [DOI] [PubMed] [Google Scholar]
  43. Jirásek J. E., Raboch J., Uher J. The relationship between the development of gonads and external genitals in human fetuses. Am J Obstet Gynecol. 1968 Jul 15;101(6):830–833. doi: 10.1016/0002-9378(68)90039-2. [DOI] [PubMed] [Google Scholar]
  44. Kelce W. R., Monosson E., Gamcsik M. P., Laws S. C., Gray L. E., Jr Environmental hormone disruptors: evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites. Toxicol Appl Pharmacol. 1994 Jun;126(2):276–285. doi: 10.1006/taap.1994.1117. [DOI] [PubMed] [Google Scholar]
  45. Kelce W. R., Stone C. R., Laws S. C., Gray L. E., Kemppainen J. A., Wilson E. M. Persistent DDT metabolite p,p'-DDE is a potent androgen receptor antagonist. Nature. 1995 Jun 15;375(6532):581–585. doi: 10.1038/375581a0. [DOI] [PubMed] [Google Scholar]
  46. Kelce W. R., Wilson E. M. Environmental antiandrogens: developmental effects, molecular mechanisms, and clinical implications. J Mol Med (Berl) 1997 Mar;75(3):198–207. doi: 10.1007/s001090050104. [DOI] [PubMed] [Google Scholar]
  47. Kristensen P., Irgens L. M., Andersen A., Bye A. S., Sundheim L. Birth defects among offspring of Norwegian farmers, 1967-1991. Epidemiology. 1997 Sep;8(5):537–544. doi: 10.1097/00001648-199709000-00011. [DOI] [PubMed] [Google Scholar]
  48. Kurzrock E. A., Baskin L. S., Li Y., Cunha G. R. Epithelial-mesenchymal interactions in development of the mouse fetal genital tubercle. Cells Tissues Organs. 1999;164(3):125–130. doi: 10.1159/000016650. [DOI] [PubMed] [Google Scholar]
  49. Källén B., Mastroiacovo P., Lancaster P. A., Mutchinick O., Kringelbach M., Martínez-Frías M. L., Robert E., Castilla E. E. Oral contraceptives in the etiology of isolated hypospadias. Contraception. 1991 Aug;44(2):173–182. doi: 10.1016/0010-7824(91)90117-x. [DOI] [PubMed] [Google Scholar]
  50. Laden F., Neas L. M., Spiegelman D., Hankinson S. E., Willett W. C., Ireland K., Wolff M. S., Hunter D. J. Predictors of plasma concentrations of DDE and PCBs in a group of U.S. women. Environ Health Perspect. 1999 Jan;107(1):75–81. doi: 10.1289/ehp.9910775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Ma L., Benson G. V., Lim H., Dey S. K., Maas R. L. Abdominal B (AbdB) Hoxa genes: regulation in adult uterus by estrogen and progesterone and repression in müllerian duct by the synthetic estrogen diethylstilbestrol (DES). Dev Biol. 1998 May 15;197(2):141–154. doi: 10.1006/dbio.1998.8907. [DOI] [PubMed] [Google Scholar]
  52. Macnab A. J., Zouves C. Hypospadias after assisted reproduction incorporating in vitro fertilization and gamete intrafallopian transfer. Fertil Steril. 1991 Nov;56(5):918–922. doi: 10.1016/s0015-0282(16)54665-2. [DOI] [PubMed] [Google Scholar]
  53. Mastroiacovo P., Spagnolo A., Marni E., Meazza L., Bertollini R., Segni G., Borgna-Pignatti C. Birth defects in the Seveso area after TCDD contamination. JAMA. 1988 Mar 18;259(11):1668–1672. [PubMed] [Google Scholar]
  54. McPhaul M. J., Marcelli M., Zoppi S., Griffin J. E., Wilson J. D. Genetic basis of endocrine disease. 4. The spectrum of mutations in the androgen receptor gene that causes androgen resistance. J Clin Endocrinol Metab. 1993 Jan;76(1):17–23. doi: 10.1210/jcem.76.1.8421085. [DOI] [PubMed] [Google Scholar]
  55. Mortlock D. P., Innis J. W. Mutation of HOXA13 in hand-foot-genital syndrome. Nat Genet. 1997 Feb;15(2):179–180. doi: 10.1038/ng0297-179. [DOI] [PubMed] [Google Scholar]
  56. Nelson K. G., Takahashi T., Bossert N. L., Walmer D. K., McLachlan J. A. Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation. Proc Natl Acad Sci U S A. 1991 Jan 1;88(1):21–25. doi: 10.1073/pnas.88.1.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. North K., Golding J. A maternal vegetarian diet in pregnancy is associated with hypospadias. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. BJU Int. 2000 Jan;85(1):107–113. doi: 10.1046/j.1464-410x.2000.00436.x. [DOI] [PubMed] [Google Scholar]
  58. Ostby J., Kelce W. R., Lambright C., Wolf C. J., Mann P., Gray L. E., Jr The fungicide procymidone alters sexual differentiation in the male rat by acting as an androgen-receptor antagonist in vivo and in vitro. Toxicol Ind Health. 1999 Jan-Mar;15(1-2):80–93. doi: 10.1177/074823379901500108. [DOI] [PubMed] [Google Scholar]
  59. Paolini M., Pozzetti L., Mesirca R., Sapone A., Cantelli-Forti G. Testosterone hydroxylase in evaluating induction and suppression of murine CYP isoenzymes by fenarimol. Arch Toxicol. 1996;70(7):451–456. doi: 10.1007/s002040050298. [DOI] [PubMed] [Google Scholar]
  60. Paulozzi L. J., Erickson J. D., Jackson R. J. Hypospadias trends in two US surveillance systems. Pediatrics. 1997 Nov;100(5):831–834. doi: 10.1542/peds.100.5.831. [DOI] [PubMed] [Google Scholar]
  61. Paulozzi L. J. International trends in rates of hypospadias and cryptorchidism. Environ Health Perspect. 1999 Apr;107(4):297–302. doi: 10.1289/ehp.99107297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Podlasek C. A., Barnett D. H., Clemens J. Q., Bak P. M., Bushman W. Prostate development requires Sonic hedgehog expressed by the urogenital sinus epithelium. Dev Biol. 1999 May 1;209(1):28–39. doi: 10.1006/dbio.1999.9229. [DOI] [PubMed] [Google Scholar]
  63. Podlasek C. A., Duboule D., Bushman W. Male accessory sex organ morphogenesis is altered by loss of function of Hoxd-13. Dev Dyn. 1997 Apr;208(4):454–465. doi: 10.1002/(SICI)1097-0177(199704)208:4<454::AID-AJA2>3.0.CO;2-H. [DOI] [PubMed] [Google Scholar]
  64. Prahalada S., Tarantal A. F., Harris G. S., Ellsworth K. P., Clarke A. P., Skiles G. L., MacKenzie K. I., Kruk L. F., Ablin D. S., Cukierski M. A. Effects of finasteride, a type 2 5-alpha reductase inhibitor, on fetal development in the rhesus monkey (Macaca mulatta). Teratology. 1997 Feb;55(2):119–131. doi: 10.1002/(SICI)1096-9926(199702)55:2<119::AID-TERA1>3.0.CO;2-Z. [DOI] [PubMed] [Google Scholar]
  65. Prener A., Engholm G., Jensen O. M. Genital anomalies and risk for testicular cancer in Danish men. Epidemiology. 1996 Jan;7(1):14–19. doi: 10.1097/00001648-199601000-00004. [DOI] [PubMed] [Google Scholar]
  66. Raman-Wilms L., Tseng A. L., Wighardt S., Einarson T. R., Koren G. Fetal genital effects of first-trimester sex hormone exposure: a meta-analysis. Obstet Gynecol. 1995 Jan;85(1):141–149. doi: 10.1016/0029-7844(94)00341-a. [DOI] [PubMed] [Google Scholar]
  67. Retik A. B., Keating M., Mandell J. Complications of hypospadias repair. Urol Clin North Am. 1988 May;15(2):223–236. [PubMed] [Google Scholar]
  68. Sharpe R. M., Skakkebaek N. E. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet. 1993 May 29;341(8857):1392–1395. doi: 10.1016/0140-6736(93)90953-e. [DOI] [PubMed] [Google Scholar]
  69. Silver R. I., Rodriguez R., Chang T. S., Gearhart J. P. In vitro fertilization is associated with an increased risk of hypospadias. J Urol. 1999 Jun;161(6):1954–1957. [PubMed] [Google Scholar]
  70. Smith E. P., Wacksman J. Evaluation of severe hypospadias. J Pediatr. 1997 Sep;131(3):344–346. doi: 10.1016/s0022-3476(97)80055-8. [DOI] [PubMed] [Google Scholar]
  71. Sonawane B. R. Chemical contaminants in human milk: an overview. Environ Health Perspect. 1995 Sep;103 (Suppl 6):197–205. doi: 10.1289/ehp.95103s6197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Stamper M. A., Norton T., Spodnick G., Marti J., Loomis M. Hypospadias in a polar bear (Ursus maritimus). J Zoo Wildl Med. 1999 Mar;30(1):141–144. [PubMed] [Google Scholar]
  73. Stoll C., Alembik Y., Roth M. P., Dott B. Genetic and environmental factors in hypospadias. J Med Genet. 1990 Sep;27(9):559–563. doi: 10.1136/jmg.27.9.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Sutherland R. W., Wiener J. S., Hicks J. P., Marcelli M., Gonzales E. T., Jr, Roth D. R., Lamb D. J. Androgen receptor gene mutations are rarely associated with isolated penile hypospadias. J Urol. 1996 Aug;156(2 Pt 2):828–831. doi: 10.1097/00005392-199608001-00077. [DOI] [PubMed] [Google Scholar]
  75. Sweet R. A., Schrott H. G., Kurland R., Culp O. S. Study of the incidence of hypospadias in Rochester, Minnesota, 1940-1970, and a case-control comparison of possible etiologic factors. Mayo Clin Proc. 1974 Jan;49(1):52–58. [PubMed] [Google Scholar]
  76. Thériault G., Iturra H., Gingras S. Evaluation of the association between birth defects and exposure to ambient vinyl chloride. Teratology. 1983 Jun;27(3):359–370. doi: 10.1002/tera.1420270310. [DOI] [PubMed] [Google Scholar]
  77. Toppari J., Larsen J. C., Christiansen P., Giwercman A., Grandjean P., Guillette L. J., Jr, Jégou B., Jensen T. K., Jouannet P., Keiding N. Male reproductive health and environmental xenoestrogens. Environ Health Perspect. 1996 Aug;104 (Suppl 4):741–803. doi: 10.1289/ehp.96104s4741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Vorherr H., Messer R. H., Vorherr U. F., Jordan S. W., Kornfeld M. Teratogenesis and carcinogenesis in rat offspring after transplacental and transmammary exposure to diethylstilbestrol. Biochem Pharmacol. 1979 Jun 15;28(12):1865–1877. doi: 10.1016/0006-2952(79)90638-5. [DOI] [PubMed] [Google Scholar]
  79. Warner M. R., Warner R. L., Clinton C. W. Reproductive tract calculi, their induction, age incidence, composition and biological effects in Balb/c Crgl mice injected as newborns with estradiol-17 beta. Biol Reprod. 1979 Mar;20(2):310–322. doi: 10.1095/biolreprod20.2.310. [DOI] [PubMed] [Google Scholar]
  80. Weidner I. S., Møller H., Jensen T. K., Skakkebaek N. E. Cryptorchidism and hypospadias in sons of gardeners and farmers. Environ Health Perspect. 1998 Dec;106(12):793–796. doi: 10.1289/ehp.98106793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Wiig O., Derocher A. E., Cronin M. M., Skaare J. U. Female pseudohermaphrodite polar bears at Svalbard. J Wildl Dis. 1998 Oct;34(4):792–796. doi: 10.7589/0090-3558-34.4.792. [DOI] [PubMed] [Google Scholar]
  82. Wilson J. D., George F. W., Griffin J. E. The hormonal control of sexual development. Science. 1981 Mar 20;211(4488):1278–1284. doi: 10.1126/science.7010602. [DOI] [PubMed] [Google Scholar]
  83. Wolf C., Jr, Lambright C., Mann P., Price M., Cooper R. L., Ostby J., Gray L. E., Jr Administration of potentially antiandrogenic pesticides (procymidone, linuron, iprodione, chlozolinate, p,p'-DDE, and ketoconazole) and toxic substances (dibutyl- and diethylhexyl phthalate, PCB 169, and ethane dimethane sulphonate) during sexual differentiation produces diverse profiles of reproductive malformations in the male rat. Toxicol Ind Health. 1999 Jan-Mar;15(1-2):94–118. doi: 10.1177/074823379901500109. [DOI] [PubMed] [Google Scholar]
  84. de Zegher F., Francois I., Boehmer A. L., Saggese G., Müller J., Hiort O., Sultan C., Clayton P., Brauner R., Cacciari E. Androgens and fetal growth. Horm Res. 1998;50(4):243–244. doi: 10.1159/000023284. [DOI] [PubMed] [Google Scholar]
  85. el-Galley R. E., Smith E., Cohen C., Petros J. A., Woodard J., Galloway N. T. Epidermal growth factor (EGF) and EGF receptor in hypospadias. Br J Urol. 1997 Jan;79(1):116–119. doi: 10.1046/j.1464-410x.1997.22624.x. [DOI] [PubMed] [Google Scholar]
  86. el-Sabeawy F., Wang S., Overstreet J., Miller M., Lasley B., Enan E. Treatment of rats during pubertal development with 2,3,7,8-tetrachlorodibenzo-p-dioxin alters both signaling kinase activities and epidermal growth factor receptor binding in the testis and the motility and acrosomal reaction of sperm. Toxicol Appl Pharmacol. 1998 Jun;150(2):427–442. doi: 10.1006/taap.1998.8426. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES